RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $837M | $637M | $987M | $495M | $1.7B | $1.6B | $1.1B | $246M | — |
| Current assets | $1.8B | $1.5B | $1.8B | $1.3B | $2.6B | $2.9B | $2.7B | $832M | — |
| Goodwill | $924M | $925M | $0 | — | — | — | — | — | — |
| Intangible assets | — | — | — | — | $0 | $5.7M | $29M | $52M | — |
| Total assets | $19.8B | $19.6B | $18.2B | $16.4B | $16.8B | $17.5B | $16.0B | $12.4B | — |
| Current liabilities | $631M | $636M | $1.3B | $161M | $1.2B | $171M | $308M | $333M | — |
| Long-term debt | $8.6B | $8.6B | $6.6B | $6.1B | $6.1B | $7.1B | $5.8B | $6.0B | — |
| Total liabilities | $10.0B | $9.9B | $7.9B | $6.3B | $7.3B | $7.3B | $6.1B | $6.3B | — |
| Shareholders' equity | $6.8B | $6.5B | $6.9B | $6.5B | $5.6B | $5.8B | $4.8B | $6.1B | $4.6B |
| Current ratio | 2.80 | 2.40 | 1.44 | 7.90 | 2.19 | 16.81 | 8.76 | 2.50 | — |